Shamburg News · 8-K filed Oct 2, 2026, 5:20 PM EDT
Tonix Pharmaceuticals Receives Paragraph IV Notice from Dr. Reddy's on TONMYA Generic ANDA
TNXP · Tonix Pharmaceuticals Holding Corp.
- Other event
- Material agreement
- Materiality: high
On October 1, 2026, Tonix Pharmaceuticals Holding Corp. received a notice from Dr. Reddy's Laboratories stating that DRL filed an ANDA with a Paragraph IV patent certification for a generic version of TONMYA 2.8 mg sublingual tablets. The certification references U.S. Patent Nos. 9636408, 9956188, 10117936 and 10864175 listed in the Orange Book. The Company stated it intends to vigorously enforce its intellectual property rights relating to TONMYA.
Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001493152-26-045603.
Written from the filing by Shamburg Markets. Figures are as reported by the company.